{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:34:26Z","timestamp":1780590866748,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multiple sclerosis (MS) is associated with increased risk of sepsis and higher sepsis-related mortality, compared to the general population. However, the evidence on the prognostic impact of MS in sepsis has been scarce. We aimed to evaluate the population-level association of MS with short-term mortality in sepsis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a retrospective population-based cohort study using a statewide data set to identify hospitalizations aged\u2009\u2265\u200918\u00a0years in Texas with sepsis, with and without MS during 2010\u20132017. Multilevel logistic models were fit to estimate the association of MS with short-term mortality among all sepsis hospitalizations, and for sensitivity analyses among hospitalizations with septic shock and those admitted to ICU.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 283,025 sepsis hospitalizations, 1687 (0.6%) had MS. Compared to sepsis hospitalizations without MS, those with MS were younger (aged\u2009\u2265\u200965\u00a0years 35.0% <jats:italic>v<\/jats:italic>s 56.8%), less commonly racial\/ethnic minority (36.2% vs 48.1%), and had lower mean Deyo comorbidity index (1.6 vs 2.7). The rates of septic shock and ICU admission were similar for sepsis hospitalizations with and without MS (58.7% vs 59.6% and 46.7% vs 46.0%, respectively). The unadjusted short-term mortality among sepsis hospitalizations with and without MS for the whole cohort, among those with septic shock, and among ICU admissions were 20.2% vs 31.3%, 25.6% vs 40.0%, and 24.0% vs 34.8%, respectively. On adjusted analyses, MS was associated with 17% lower odds of short-term mortality (adjusted odds ratio [aOR] 0.828 [95% CI 0.723\u20130.947]). Similar findings were observed on sensitivity analyses of patients with septic shock (aOR 0.764 [95% CI 0.651\u20130.896]), but MS was not associated with mortality among sepsis hospitalizations admitted to ICU (aOR 0.914 [95% CI 0.759\u20131.101]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MS was associated with lower short-term mortality among septic patients, with findings consistent among the subset with septic shock. Among septic patients admitted to ICU, MS was not associated with mortality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40560-022-00628-1","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T07:25:37Z","timestamp":1658733937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of multiple sclerosis with mortality in sepsis: a population-level analysis"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-6845","authenticated-orcid":false,"given":"Lavi","family":"Oud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"628_CR1","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG, US Multiple Sclerosis Prevalence Workgroup. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92:e1029\u201340.","journal-title":"Neurology"},{"key":"628_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jnnp-2011-300616","volume":"83","author":"E Kingwell","year":"2012","unstructured":"Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, Tremlett H. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry. 2012;83:61\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"628_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1352458506075651","volume":"13","author":"M DeS\u00e8ze","year":"2007","unstructured":"DeS\u00e8ze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B, GENULF. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13:915\u201328.","journal-title":"Mult Scler"},{"key":"628_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056676","volume":"8","author":"N Srour","year":"2013","unstructured":"Srour N, LeBlanc C, King J, McKim DA. Lung volume recruitment in multiple sclerosis. PLoS ONE. 2013;8: e56676.","journal-title":"PLoS ONE"},{"key":"628_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cei.12226","volume":"175","author":"A Winkelmann","year":"2014","unstructured":"Winkelmann A, Loebermann M, Reisinger EC, Zettl UK. Multiple sclerosis treatment and infectious issues: update 2013. Clin Exp Immunol. 2014;175:425\u201338.","journal-title":"Clin Exp Immunol"},{"key":"628_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7224\/1537-2073.2014-035","volume":"17","author":"RE Nelson","year":"2015","unstructured":"Nelson RE, Xie Y, DuVall SL, Butler J, Kamauu AWC, Knippenberg K, Schuerch M, Foskett N, LaFleur J. Multiple sclerosis and risk of infection-related hospitalization and death in US veterans. Int J MS Care. 2015;17:221\u201330.","journal-title":"Int J MS Care"},{"key":"628_CR7","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1212\/WNL.0000000000000495","volume":"82","author":"RA Marrie","year":"2014","unstructured":"Marrie RA, Bernstein CN, Peschken CA, Hitchon CA, Chen H, Fransoo R, Garland A. Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality. Neurology. 2014;82:2112\u20139.","journal-title":"Neurology"},{"key":"628_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105207","volume":"9","author":"DS Goodin","year":"2014","unstructured":"Goodin DS, Corwin M, Kaufman D, Golub H, Reshef S, Rametta MJ, Knappertz V, Cutter G, Pleimes D. Causes of death among commercially insured multiple sclerosis patients in the United States. PLoS ONE. 2014;9: e105207.","journal-title":"PLoS ONE"},{"key":"628_CR9","doi-asserted-by":"publisher","first-page":"e820","DOI":"10.1212\/WNL.0000000000008907","volume":"94","author":"K Harding","year":"2020","unstructured":"Harding K, Zhu F, Alotaibi M, Duggan T, Tremlett H, Kingwell E. Multiple cause of death analysis in multiple sclerosis: a population-based study. Neurology. 2020;94:e820\u20139.","journal-title":"Neurology"},{"key":"628_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.msard.2015.08.005","volume":"4","author":"G Capkun","year":"2015","unstructured":"Capkun G, Dahlke F, Lahoz R, Nordstrom B, Tilson HH, Cutter G, Bischof D, Moore A, Simeone J, Fraeman K, Bancken F, Geissb\u00fchler Y, Wagner M, Cohan S. Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Mult Scler Relat Disord. 2015;4:546\u201354.","journal-title":"Mult Scler Relat Disord"},{"key":"628_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13054-019-2357-1","volume":"23","author":"M Sheth","year":"2019","unstructured":"Sheth M, Benedum CM, Celi LA, Mark RG, Markuzon N. The association between autoimmune disease and 30-day mortality among sepsis ICU patients: a cohort study. Crit Care. 2019;23:93.","journal-title":"Crit Care"},{"key":"628_CR12","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.","journal-title":"PLoS Med"},{"key":"628_CR13","unstructured":"Texas inpatient public use data file. Texas Department of State Health Services, Center for Health Statistics, Austin, Texas. 2018. http:\/\/www.dshs.state.tx.us\/thcic\/hospitals\/Inpatientpudf.shtm. Accessed 23 July 2021"},{"key":"628_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"628_CR15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","volume":"318","author":"C Rhee","year":"2017","unstructured":"Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, Kadri SS, Angus DC, Danner RL, Fiore AE, Jernigan JA, Martin GS, Septimus E, Warren DK, Karcz A, Chan C, Menchaca JT, Wang R, Gruber S, Klompas M, CDC Prevention Epicenter Program. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014. JAMA. 2017;318:1241\u20139.","journal-title":"JAMA"},{"key":"628_CR16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/CCM.0000000000003005","volume":"46","author":"HC Prescott","year":"2018","unstructured":"Prescott HC, Cope TM, Gesten FC, Ledneva TA, Friedrich ME, Iwashyna TJ, Osborn TM, Seymour CW, Levy MM. Reporting of sepsis cases for performance measurement versus for reimbursement in New York State. Crit Care Med. 2018;46:666\u201373.","journal-title":"Crit Care Med"},{"key":"628_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/CCM.0000000000004224","volume":"48","author":"TG Buchman","year":"2020","unstructured":"Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M, Chavan S, Oke I, Pennini ME, Santhosh A, Wax M, Woodbury R, Chu S, Merkeley TG, Disbrow GL, Bright RA, MaCurdy TE, Kelman JA. Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012\u20132018. Crit Care Med. 2020;48:276\u201388.","journal-title":"Crit Care Med"},{"key":"628_CR18","volume":"2013","author":"S Nusrat","year":"2013","unstructured":"Nusrat S, Levinthal D, Bielefeldt K. Hospitalization rates and discharge status in multiple sclerosis. Mult Scler Int. 2013;2013: 436929.","journal-title":"Mult Scler Int"},{"issue":"15 Supplement","key":"628_CR19","first-page":"42","volume":"92","author":"MR Afzal","year":"2019","unstructured":"Afzal MR, Yao J, Bandaru H, Qureshi M, Ghatali M, Vellipuram A, Khatri RA, Kassar D, Maud A, Rodriguez G, Cruz-Flores S. Multiple sclerosis (MS) and neuromyelitis optica (NMO): admission trends, in-hospital events, outcomes, treatment and regional differences in distribution: a study of the national inpatient sample 2006\u20132014. Neurology. 2019;92(15 Supplement):42\u2013064.","journal-title":"Neurology"},{"key":"628_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ofid\/ofy313","volume":"5","author":"Y Sakr","year":"2018","unstructured":"Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, \u00d1amendys-Silva SA, Martin-Loeches I, Leone M, Lupu MN, Vincent JL, ICON Investigators. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018;5:313.","journal-title":"Open Forum Infect Dis"},{"key":"628_CR21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1378\/chest.11-0352","volume":"140","author":"G Kumar","year":"2011","unstructured":"Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, Jimenez E, Mohan A, Khan RA, Whittle J, Jacobs E, Nanchal R, Milwaukee Initiative in Critical Care Outcomes Research (MICCOR) Group of Investigators. Nationwide trends of severe sepsis in the 21st century (2000\u20132007). Chest. 2011;140:1223\u201331.","journal-title":"Chest"},{"key":"628_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"DC Angus","year":"2001","unstructured":"Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303\u201310.","journal-title":"Crit Care Med"},{"key":"628_CR23","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139.","journal-title":"Med Care"},{"key":"628_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382.","journal-title":"Am J Epidemiol"},{"key":"628_CR25","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"2003","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546\u201354.","journal-title":"N Engl J Med"},{"key":"628_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1164\/rccm.202106-1350OC","volume":"205","author":"GL Anesi","year":"2022","unstructured":"Anesi GL, Liu VX, Chowdhury M, Small DS, Wang W, Delgado MK, Bayes B, Dress E, Escobar GJ, Halpern SD. Association of ICU admission and outcomes in sepsis and acute respiratory failure. Am J Respir Crit Care Med. 2022;205:520\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"628_CR27","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374.","journal-title":"Nat Rev Immunol"},{"key":"628_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/165974","volume":"2013","author":"W Schulte","year":"2013","unstructured":"Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets\u2013an updated view. Mediators Inflamm. 2013;2013: 165974.","journal-title":"Mediators Inflamm"},{"key":"628_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340\u201350.","journal-title":"N Engl J Med"},{"key":"628_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-0171-8_1","volume":"520","author":"P Santamaria","year":"2003","unstructured":"Santamaria P. Cytokines and chemokines in autoimmune disease: an overview. Adv Exp Med Biol. 2003;520:1\u20137.","journal-title":"Adv Exp Med Biol"},{"key":"628_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1073\/pnas.94.2.599","volume":"94","author":"KE Balashov","year":"1997","unstructured":"Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci USA. 1997;94:599\u2013603.","journal-title":"Proc Natl Acad Sci USA"},{"key":"628_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1352458518763094","volume":"24","author":"K G\u00f6bel","year":"2018","unstructured":"G\u00f6bel K, Ruck T, Meuth SG. Cytokine signaling in multiple sclerosis: lost in translation. Mult Scler. 2018;24:432\u20139.","journal-title":"Mult Scler"},{"key":"628_CR33","first-page":"349","volume":"65","author":"OH Kantarci","year":"2008","unstructured":"Kantarci OH, Hebrink DD, Schaefer-Klein J, Sun Y, Achenbach S, Atkinson EJ, Heggarty S, Cotleur AC, de Andrade M, Vandenbroeck K, Pelfrey CM, Weinshenker BG. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression. Arch Neurol. 2008;65:349\u201357.","journal-title":"Arch Neurol"},{"key":"628_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0022-510X(02)00420-3","volume":"206","author":"HF Petereit","year":"2003","unstructured":"Petereit HF, Pukrop R, Fazekas F, Bamborschke SU, R\u00f6pele S, K\u00f6lmel HW, Merkelbach S, Japp G, Jongen PJ, Hartung HP, Hommes OR. Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis. J Neurol Sci. 2003;206:209\u201314.","journal-title":"J Neurol Sci"},{"issue":"3","key":"628_CR35","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1128\/IAI.69.3.1394-1401.2001","volume":"69","author":"RC Reddy","year":"2001","unstructured":"Reddy RC, Chen GH, Newstead MW, Moore T, Zeng X, Tateda K, Standiford TJ. Alveolar macrophage deactivation in murine septic peritonitis: role of interleukin 10. Infect Immun. 2001;69(3):1394\u2013401.","journal-title":"Infect Immun"},{"key":"628_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1385\/IR:24:3:273","volume":"24","author":"RC Reddy","year":"2001","unstructured":"Reddy RC, Chen GH, Tekchandani PK, Standiford TJ. Sepsis-induced immunosuppression: from bad to worse. Immunol Res. 2001;24:273\u201387.","journal-title":"Immunol Res"},{"key":"628_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9610(01)00754-1","volume":"182","author":"S Ono","year":"2001","unstructured":"Ono S, Ueno C, Aosasa S, Tsujimoto H, Seki S, Mochizuki H. Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis. Am J Surg. 2001;182:491\u20137.","journal-title":"Am J Surg"},{"key":"628_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102893","volume":"20","author":"M Dema","year":"2021","unstructured":"Dema M, Eixarch H, Villar LM, Montalban X, Espejo C. Immunosenescence in multiple sclerosis: the identification of new therapeutic targets. Autoimmun Rev. 2021;20: 102893.","journal-title":"Autoimmun Rev"},{"key":"628_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103776","volume":"75","author":"A Baghela","year":"2022","unstructured":"Baghela A, Pena OM, Lee AH, Baquir B, Falsafi R, An A, Farmer SW, Hurlburt A, Mondragon-Cardona A, Rivera JD, Baker A, Trahtemberg U, Shojaei M, Jimenez-Canizales CE, Dos Santos CC, Tang B, Bouma HR, Cohen Freue GV, Hancock REW. Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures. EBioMedicine. 2022;75: 103776.","journal-title":"EBioMedicine"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-022-00628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-022-00628-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-022-00628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T07:28:30Z","timestamp":1658734110000},"score":1,"resource":{"primary":{"URL":"https:\/\/jintensivecare.biomedcentral.com\/articles\/10.1186\/s40560-022-00628-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1186\/s40560-022-00628-1","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable; de-identified data were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}